Olympus Accelerates Local Production of the EVIS X1™ Endoscopy System in ChinaChina-manufactured video processor obtains medical device registration certificate

November 28, 2025

---

　

＜notice＞
SHANGHAI, November 28, 2025 – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, announced that its CV-1500-C video processor of the EVIS X1™ endoscopy system has officially obtained the Medical Device Registration Certificate from the MPA (Jiangsu Medical Products Administration).
Olympus obtained MPA approval for the GIF-EZ1500-C gastroscope of the EVIS X1 in August 2025, and with this latest approval, the company will further accelerate its efforts toward local production of its flagship endoscopy system, EVIS X1, in China.

Olympus has also received MPA registration certificates in October 2025 for the OTV-S700-C video processor and the CLL-S700-C high-intensity light source for the VISERA ELITE™ III surgical visualization platform. The GIF-EZ1500-C gastroscope has been manufactured since November 2025 at Olympus (Suzhou) Medical Device Co.,Ltd.. Olympus will continue to advance regulatory preparations toward the market launch of locally made products in China.

The Chinese market has always been one of the most important strategic regions for Olympus. The annual number of gastrointestinal endoscopy procedures in China is approximately 59 million. However, the number of endoscopists is low relative to the population, so Olympus is dedicated to training physicians. Olympus operates training centers in Beijing, Shanghai, and Guangzhou, providing training venues and learning programs for healthcare professionals.

Olympus is dedicated to developing the future of endoscopy-enabled care by introducing innovative products and high-value-added solutions. In China, through expert services and structured training programs, the company aims to empower clinicians and enhance patient outcomes across the region. By manufacturing locally and collaborating closely with healthcare professionals, Olympus reaffirms its long-term commitment to China and its role in advancing patient care and the development of the healthcare industry.

About EVIS X1

Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with advanced imaging technologies including TXI™ mode, NBI™ mode and RDI™ mode (Red Dichromatic Imaging). These proprietary innovations have contributed to more precise observation and treatment of gastrointestinal and respiratory diseases, including cancer.

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global LinkedIn and X accounts.